TABLE 5.
Susceptibilities to potentially active drugs of all isolates of ESBL-positive Enterobacteriaceaea
| ESBL type | No. of isolates | % Susceptibility to drug
 | 
|||||||
|---|---|---|---|---|---|---|---|---|---|
| Imipenem | Cefoxitin | Amoxicillin plus clavulanate | Piperacillin plus tazobactam | Ampicillin plus sulbactam | Gentamicin | Amikacin | Ciprofloxacin | ||
| TEM+ | 234 | 99.6 | 79 | 82 | 95 | 69 | 45 | 68 | 32 | 
| SHV+ | 173 | 100 | 79 | 88 | 88 | 59 | 66 | 86 | 85 | 
| TEM+ and SHV+ | 55 | 100 | 75 | 78 | 84 | 47 | 71 | 69 | 76 | 
| Non-TEM/non-SHV | 38 | 100 | 76 | 97 | 89 | 39 | 55 | 95 | 71 | 
| Total | 500 | 99.8 | 78 | 85 | 91 | 61 | 56 | 76 | 58 | 
MICs have been interpreted according to current NCCLS criteria (23).